Literature DB >> 33479067

Management of functional gastrointestinal disorders.

Asma Fikree1, Peter Byrne2.   

Abstract

Functional gastrointestinal (GI) disorders (eg irritable bowel syndrome and functional dyspepsia) are very common conditions which are associated with very poor quality of life and high healthcare utilisation. They are caused by disorders of GI functioning, namely altered gut sensitivity, motility, microbiota, immune functioning and central nervous system processing. They cause chronic symptoms throughout the gut (eg pain, dyspepsia and altered bowel habit), all of which are made worse by maladaptive patient behaviours, stress and psychological comorbidity. Management involves a biopsychosocial approach involving changes in lifestyle and diet, addressing coexisting psychological comorbidity and using medication to treat underlying pathophysiology. Pharmacological treatment with antispasmodics, neuromodulators, motility agents and antidepressants is effective. Psychotherapy in motivated individuals is equally effective. Success of treatment is increased by a good doctor-patient relationship and so this needs to be taken into account during the consultation. © Royal College of Physicians 2021. All rights reserved.

Entities:  

Keywords:  functional disorders; functional dyspepsia; gastrointestinal; irritable bowel syndrome; pain

Mesh:

Year:  2021        PMID: 33479067      PMCID: PMC7850201          DOI: 10.7861/clinmed.2020-0980

Source DB:  PubMed          Journal:  Clin Med (Lond)        ISSN: 1470-2118            Impact factor:   2.659


  59 in total

Review 1.  Cannabidiol Adverse Effects and Toxicity.

Authors:  Marilyn A Huestis; Renata Solimini; Simona Pichini; Roberta Pacifici; Jeremy Carlier; Francesco Paolo Busardò
Journal:  Curr Neuropharmacol       Date:  2019       Impact factor: 7.363

2.  The adverse health effects and harms related to marijuana use: an overview review.

Authors:  K Ally Memedovich; Laura E Dowsett; Eldon Spackman; Tom Noseworthy; Fiona Clement
Journal:  CMAJ Open       Date:  2018-08-16

Review 3.  The efficacy and safety of probiotics for patients with constipation-predominant irritable bowel syndrome: A systematic review and meta-analysis based on seventeen randomized controlled trials.

Authors:  Yong Wen; Jun Li; Qing Long; Chao-Chi Yue; Bing He; Xue-Gui Tang
Journal:  Int J Surg       Date:  2020-05-06       Impact factor: 6.071

4.  A Randomized Controlled Trial Comparing the Low FODMAP Diet vs. Modified NICE Guidelines in US Adults with IBS-D.

Authors:  Shanti L Eswaran; William D Chey; Theresa Han-Markey; Sarah Ball; Kenya Jackson
Journal:  Am J Gastroenterol       Date:  2016-10-11       Impact factor: 10.864

5.  Clinical trial: short- and long-term benefit of relaxation training for irritable bowel syndrome.

Authors:  P P J van der Veek; Y R van Rood; A A M Masclee
Journal:  Aliment Pharmacol Ther       Date:  2007-09-15       Impact factor: 8.171

Review 6.  Effect of antidepressants and psychological therapies, including hypnotherapy, in irritable bowel syndrome: systematic review and meta-analysis.

Authors:  Alexander C Ford; Eamonn M M Quigley; Brian E Lacy; Anthony J Lembo; Yuri A Saito; Lawrence R Schiller; Edy E Soffer; Brennan M R Spiegel; Paul Moayyedi
Journal:  Am J Gastroenterol       Date:  2014-06-17       Impact factor: 10.864

7.  Sleep disturbances are linked to both upper and lower gastrointestinal symptoms in the general population.

Authors:  F Cremonini; M Camilleri; A R Zinsmeister; L M Herrick; T Beebe; N J Talley
Journal:  Neurogastroenterol Motil       Date:  2008-09-18       Impact factor: 3.598

Review 8.  Efficacy of psychotropic drugs in functional dyspepsia: systematic review and meta-analysis.

Authors:  Alexander C Ford; Pavit Luthra; Jan Tack; Guy E Boeckxstaens; Paul Moayyedi; Nicholas J Talley
Journal:  Gut       Date:  2015-11-13       Impact factor: 23.059

9.  Low-dose imipramine for refractory functional dyspepsia: a randomised, double-blind, placebo-controlled trial.

Authors:  Pui Kuan Cheong; Alexander C Ford; Cynthia K Y Cheung; Jessica Y L Ching; Yawen Chan; Joseph J Y Sung; Francis K L Chan; Justin C Y Wu
Journal:  Lancet Gastroenterol Hepatol       Date:  2018-10-22

10.  Low-Dose Linaclotide (72 μg) for Chronic Idiopathic Constipation: A 12-Week, Randomized, Double-Blind, Placebo-Controlled Trial.

Authors:  Philip Schoenfeld; Brian E Lacy; William D Chey; Anthony J Lembo; Caroline B Kurtz; David S Reasner; Wieslaw Bochenek; Kenneth Tripp; Mark G Currie; Susan M Fox; Rick E Blakesley; Christopher R OʼDea; Nicholas D Omniewski; Michael L Hall
Journal:  Am J Gastroenterol       Date:  2017-08-22       Impact factor: 10.864

View more
  5 in total

1.  Finding your own way to manage patients with functional disorders.

Authors:  Anton Emmanuel
Journal:  Clin Med (Lond)       Date:  2021-01       Impact factor: 2.659

2.  Initial assessment of patients with putative functional disorders in medical settings.

Authors:  Peter Tyrer; Charles Fox; Catherine Gardiner; Roger Mulder; Helen Tyrer
Journal:  Clin Med (Lond)       Date:  2021-01       Impact factor: 2.659

Review 3.  Treatment of Gastrointestinal Disorders-Plants and Potential Mechanisms of Action of Their Constituents.

Authors:  Szilvia Czigle; Silvia Bittner Fialová; Jaroslav Tóth; Pavel Mučaji; Milan Nagy
Journal:  Molecules       Date:  2022-04-30       Impact factor: 4.927

Review 4.  Diet, fibers, and probiotics for irritable bowel syndrome.

Authors:  Adelina Nicoleta Galica; Reitano Galica; Dan Lucian Dumitrașcu
Journal:  J Med Life       Date:  2022-02

Review 5.  The Importance of Nutrition as a Lifestyle Factor in Chronic Pain Management: A Narrative Review.

Authors:  Ömer Elma; Katherine Brain; Huan-Ji Dong
Journal:  J Clin Med       Date:  2022-10-09       Impact factor: 4.964

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.